哮喘患者血浆IL-13、LTB-4、MMP-9、TIMP-1变化及临床意义被引量：15

Study on the Significance of Changes of Plasma IL-13,LTB-4,MMP-9,TIMP-1 Levels in Patients with Asthma

下载PDF

导出

摘要目的:探讨哮喘患者血浆IL-13、白三烯B4(LTB-4)、基质金属蛋白酶9(MMP-9)和基质金属蛋白酶组织抑制剂1(TIMP-1)变化及临床意义。方法:选择哮喘患者及查体健康者(对照组)各30例,检测哮喘组急性发作期及稳定期的血浆IL-13、LTB-4、TIMP-1及TIMP-1/MMP-9比值,且与对照组比较;并对哮喘组各检测指标进行相关性分析。结果:哮喘组急性发作期血浆IL-13、LTB-4、MMP-9、TIMP-1及MMP-9/TIMP-1比值明显高于稳定期(P均<0.05),上述指标均明显高于对照组(P均<0.01);IL-13与LTB-4、MMP-9与TIMP-1、MMP-9、TIMP-1与TIMP-1/MMP-9比值均呈显著正相关(r分别为0.841、0.832、0.921、0.579,P均<0.05)。结论:IL-13、LTB-4升高及MMP-9/TIMP-1失衡参与哮喘发病,检测IL-13、LTB-4、MMP-9、TIMP-1、TIMP-1/MMP-9比值可评估哮喘病情,指导治疗。 Objective To study the significance of changes of plasma IL-13,LTB-4,MMP-9,TIMP-1 levels in patients with asthma.Methods Plasma levels of IL-13,leukotriene B4（LTB4）,MMP-9 and TIMP-1 were determined with ELISA in 30 patients with asthma both on admission and after stabilized as well as once in 30 controls.Results Plasma levels of IL-13,LTB-4,MMP-9 and TIMP-1 in patients with asthma on admission were significantly higher than those in patients stabilized（P〈0.05）and the levels in patients stabilized were still significantly higher than those in controls（P〈0.01）.Conclusion Changes of plasma levels of IL-13,LTB-4,MMP-9 and TIMP-1 could reflect the severity of disease in patients with asthma and monitoring of the changes would be helpful for assessment of the progress of disease.

作者朱艳

机构地区浙江省丽水市人民医院呼吸内科

出处《放射免疫学杂志》 CAS 2010年第4期429-431,共3页 Journal of Radioimmanology

关键词哮喘白细胞介素13 白三烯B4 基质金属蛋白酶9 基质金属蛋白酶组织抑制剂1 asthma IL-13 LTB-4 MMP-9 TIMP-1

分类号 R735.1 [医药卫生—肿瘤]

引文网络
相关文献

参考文献10

1中华医学会呼吸病学分会哮喘学组.哮喘诊治指南(2007年修订版).中华结核和呼吸杂志,2007,30(1):8-8.
2Rubin P,Mollison KW.Pharmaccotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids[J].Prostaglandins Other Lipid Mediat,2007,83(3):188-197.
3Cohn L,Whittaker L,Niu N,et al.Cytokine regulation of mucus production in a model of allergic asthma[J].Novartis Found Symp,2002,248(2):201-213.
4Sapey E,Bayley D,Ahmad A,et al.Inter-relationships between inflammatory markers in patients with stable asthma with bronchitis:intrapatient and inter-patient variability[J].Thorax,2008,63(6):493-499.
5Beeh KM,Kommann O,Buhl R,et al.Neutrophil chemotactic activity of sputum from patients with asthma:role of interleukin 8 and leukotriene B4[J].Chest,2003,123(4):983-986.
6Nenan S,Lagente V,Planquois JM,et al.Metalloelastase(MMP9)induced inflammatory response in mice airways:effects of dexamethasone,rolipram and marimastat[J].EurJ Pharmacol,2007,559(1):75-81.
7Joos L,He JQ,Shepherdson MB,et al.The role of matrixmetalloproteinase polymorphisms in the rate of decline in lung function[J].Hum Mol Genet,2003,12(7):569-576.
8Mattos W,Lim S,Russell R,et al.Matrixmetalloproteinase-9 expression in asthma effect of asthma severity,allergen challenge,and inhaled corticosteroids[J].Chest,2002,122:1543-1552.
9Kelly EA,Busse WW,Jarjour NN.Increased matrix metalloproteinase-9 in the airway after allergen challenge[J].Am J Respir Crit Med,2000,162(3pt1):1157-1161.
10Palmans E,Kips JC,Pauwels RA.Prolonged allergen exposure induces structural airway changes in sensitized rats[J].Am J Respir Crit Care Med,2000,161(2Pt1):627-635.